NCT01247922 2024-12-06Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205Astellas Pharma IncPhase 2 Terminated4 enrolled 9 charts
NCT03257631 2024-04-16A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain TumorsCelgenePhase 2 Completed53 enrolled 18 charts
NCT00520936 2011-02-25A Study of Pemetrexed in Children With Recurrent CancerEli Lilly and CompanyPhase 2 Completed72 enrolled 17 charts